Clinical Trials Logo

Radiomics clinical trials

View clinical trials related to Radiomics.

Filter by:

NCT ID: NCT06452550 Recruiting - Radiomics Clinical Trials

Neurophenotype Predicts CD Disease Progression

Start date: May 1, 2021
Phase:
Study type: Observational

The goal of this observational study is aimed to develop a novel multimodal neuroimaging-based model to characterize the neurophenotype of Crohn's Disease patients and assess its ability for predicting disease progression, using multiomics data to interpret the model. Participants will be followed-up of at least six months for patients without disease progression to assess the relationship between neurophenotype and intestinal outcomes.

NCT ID: NCT06381895 Completed - Bladder Cancer Clinical Trials

The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer

Start date: May 30, 2023
Phase:
Study type: Observational

The aim of this study was to develop an radiomic model based on CT images to evaluate markers of the bladder cancer microenvironment, such as TSR,TIL, and IP. Secondly, the association of the radiomic model with clinical outcomes and immunotherapy response was investigated.

NCT ID: NCT06167863 Completed - Clinical trials for Artificial Intelligence

Retrospective Analysis of the Correlation Between Imaging Features and Pathology, Prognosis in Renal Tumors

Start date: August 31, 2023
Phase:
Study type: Observational

Renal cell carcinoma (RCC) is the most common malignant tumor in the kidney with a high mortality rate. Traditional imaging techniques are limited in capturing the internal heterogeneity of the tumor. Radiomics provides internal features of lesions for precise diagnosis, prognosis prediction, and personalized treatment planning. Early and accurate diagnosis of renal tumors is crucial, but it's challenging due to morphological and pathological overlap between benign and malignant lesions. The accurate diagnosis of RCC, especially for small tumors, remains a significant challenge. Recent studies have shown a relationship between body composition, obesity, and renal tumors. Common indicators like body weight and BMI fail to reflect body composition accurately. Research on the role of body composition, including adipose tissue, in tumor pathology could improve clinical diagnosis and treatment planning.

NCT ID: NCT06062173 Active, not recruiting - Radiomics Clinical Trials

Preoperative Prediction of Adherent Perirenal Fat.

APF
Start date: January 5, 2020
Phase:
Study type: Observational

In addition to kidney tumor specific factors, adherent perirenal fat is one of the most important causes of technical complications in kidney surgery, and currently, there is a lack of widely used non-invasive predictive models in clinical practice. In this study, a deep learning algorithm based on CT imaging and nomogram was proposed to identify and predict the presence of adherent perirenal fat. This study includes the construction of a prediction model based on CT imaging and the verification of the prediction model.

NCT ID: NCT05889949 Active, not recruiting - Clinical trials for Hepatocellular Carcinoma (HCC)

Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

Start date: June 1, 2019
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to explore the role of prediction of microvascular invasion by radiomics based on pre-treatment magnetic resonance imaging for guiding treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.

NCT ID: NCT05784207 Completed - Clinical trials for Idiopathic Pulmonary Fibrosis

An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors

Start date: June 1, 2017
Phase:
Study type: Observational

The purpose of this study is to compare AI performance to doctor's performance in the evaluation of IPF/UIP and ILDs without UIP(proven by biopsy).

NCT ID: NCT05761912 Not yet recruiting - Prostate Cancer Clinical Trials

Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy

Start date: March 15, 2023
Phase:
Study type: Observational

To predict prostate cancer and its prognosis by ultrasound radiomics in ultrasound fusion prostate targeted biopsy.

NCT ID: NCT05736991 Recruiting - Lung Adenocarcinoma Clinical Trials

Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma

Start date: November 1, 2022
Phase:
Study type: Observational

The purpose of this study is to evaluate the performance of a PET/ CT-based deep learning signature for predicting the grade 3 tumors based on the novel grading system in clinical stage stage I lung adenocarcinoma based on a multicenter prospective cohort.

NCT ID: NCT05517889 Completed - Clinical trials for Artificial Intelligence

Repeatability and Stability of Healthy Skin Features on OCT

Start date: September 1, 2022
Phase:
Study type: Observational

A test-retest study on the stability and repeatability of healthy skin features on OCT

NCT ID: NCT05369689 Not yet recruiting - Prognosis Clinical Trials

Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics

Start date: June 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study aims to assess multimodal Radiomics-based prediction model for prognostic prediction in spinal tumors.